β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases-Reference-Cited by-同舟云学术

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases

Published:2016-02-09 Issue:4 Volume:33 Page:309-323
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Bleckmann Annalen,Conradi Lena-Christin,Menck Kerstin,Schmick Nadine Annette,Schubert Antonia,Rietkötter Eva,Arackal Jetcy,Middel Peter,Schambony Alexandra,Liersch Torsten,Homayounfar Kia,Beißbarth Tim,Klemm Florian,Binder Claudia,Pukrop Tobias

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10585-016-9780-3.pdf

Reference61 articles.

1. De Angelis R et al (2014) Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15(1):23–34

2. Cardoso F et al. (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) dagger. Annals of oncology: Official Journal of the European Society for Medical Oncology/ESMO vol 25(10), pp 1871–88

3. Ruiterkamp J, Ernst MF (2011) The role of surgery in metastatic breast cancer. Eur J Cancer 47(Suppl 3):S6–S22

4. Choti MA (2014) Liver-directed treatments for metastatic colorectal cancer. Curr Treat Options Oncol 15(3):456–464

5. Elsberger B, Roxburgh CS, Horgan PG (2014) Is there a role for surgical resections of hepatic breast cancer metastases? Hepatogastroenterology 61(129):181–186

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through the PI3K/Akt/mTOR pathway-mediated autophagy induction;Archives of Biochemistry and Biophysics;2024-09

2. Molecular pathways of common breast cancer metastases and the distinguishing features of triple-negative breast cancer;Archives of Current Medical Research;2024-05-31

3. A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer;Breast Cancer Research;2024-02-26

4. Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression;Cell Communication and Signaling;2023-07-10

5. Triple-Negative Breast Cancer-Derived Extracellular Vesicles Promote a Hepatic Premetastatic Niche via a Cascade of Microenvironment Remodeling;Molecular Cancer Research;2023-04-11